1. Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer
    Barbara Chiavarina et al, 2017, IJMS CrossRef
  2. The Warburg effect and glucose-derived cancer theranostics
    Rakesh K. Tekade et al, 2017, Drug Discovery Today CrossRef
  3. Antiproliferative effect of p -Coumaric acid targets UPR activation by downregulating Grp78 in colon cancer
    Sharada H. Sharma et al, 2018, Chemico-Biological Interactions CrossRef
  4. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy
    Gang Wang et al, 2018, J Cell Physiol CrossRef
  5. Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications
    Ibrahim El Halabi et al, 2018, IJMS CrossRef
  6. Novel Targets in Advanced Colorectal Cancer
    Joycelyn Jie Xin Lee et al, 2018, Curr Colorectal Cancer Rep CrossRef
  7. Colorectal Cancer and Metabolism
    Rachel E. Brown et al, 2018, Curr Colorectal Cancer Rep CrossRef
  8. pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks
    Ege Ulgen et al, 2019, Front. Genet. CrossRef
  9. Reverse Warburg Effect-Related Mitochondrial Activity and 18F-FDG Uptake in Invasive Ductal Carcinoma
    Byung Wook Choi et al, 2019, Nucl Med Mol Imaging CrossRef
  10. Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
    Manish Pratap Singh et al, 2019, Genes & Diseases CrossRef
  11. Mitochondrial Respiration in KRAS and BRAF Mutated Colorectal Tumors and Polyps
    Egle Rebane-Klemm et al, 2020, Cancers CrossRef
  12. Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer
    Wenming Feng et al, 2017, Oncotarget CrossRef
  13. Free fatty acids receptors 2 and 3 control cell proliferation by regulating cellular glucose uptake
    Saeed Al Mahri et al, 2020, WJGO CrossRef
  14. Phosphorylation of Ser6 in hnRNPA1 by S6K2 regulates glucose metabolism and cell growth in colorectal cancer
    Yan Sun et al, 2017, Oncol Lett CrossRef
  15. Bioinformatic analysis of CCA-1.1, a novel curcumin analog, uncovers furthermost noticeable target genes in colon cancer
    Febri Wulandari et al, 2020, Gene Reports CrossRef
  16. Hemistepsin A suppresses colorectal cancer growth through inhibiting pyruvate dehydrogenase kinase activity
    Ling Jin et al, 2020, Sci Rep CrossRef
  17. Survival prediction in patients with colon adenocarcinoma via multi-omics data integration using a deep learning algorithm.
    Jiudi Lv et al, 2020, Biosci Rep CrossRef
  18. Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
    Tiago De Oliveira et al, 2021, Cancers CrossRef
  19. null
    Pradip Kumar Jaiswara et al, 2021 CrossRef
  20. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
    Aldona Kasprzak, 2021, IJMS CrossRef
  21. Metabolic changes in colorectal carcinomas are key factors for the early detection of neoplastic change
    Voke Peter Orugbo et al, 2021, Ann Clin Biomed Res CrossRef
  22. The inflammatory tumor microenvironment and tumor cell plasticity in the pathogenesis of colorectal cancer
    A.I. Stukan et al, 2021, Onkol. Z. im. P.A. Gercena CrossRef
  23. Genetic Mutations and Non-Coding RNA-Based Epigenetic Alterations Mediating the Warburg Effect in Colorectal Carcinogenesis
    Batoul Abi Zamer et al, 2021, Biology CrossRef
  24. Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer
    Xiaolin Zhang et al, 2021, Biomolecules CrossRef
  25. Identification and validation of a metabolism-related gene signature for the prognosis of colorectal cancer: a multicenter cohort study
    Ping Han et al, 2022 CrossRef
  26. Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer
    Bonnie Yang Yang et al, 2022, IJMS CrossRef
  27. Enhancing an Oxidative “Trojan Horse” Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside
    Agata N. Burska et al, 2022, Cells CrossRef
  28. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
    Soumik Pal et al, 2022, Front. Immunol. CrossRef
  29. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
    Ghada M K GabAllah et al, 2017, Saudi J Gastroenterol CrossRef
  30. Proteome profiling of endogenous and potential S-nitrosylation in colorectal cancer
    Feng Liang et al, 2023, Front. Endocrinol. CrossRef
  31. Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines
    Archana Bharti Sonkar et al, 2023, International Immunopharmacology CrossRef
  32. CDK6: an attractive therapeutic target for T-ALL/LBL
    Wei, Li et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
  33. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
    Minru Liao et al, 2023, Acta Pharmaceutica Sinica B CrossRef
  34. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers
    Arefeh Zabeti Touchaei et al, 2024, Clin Exp Med CrossRef
  35. Uncovering novel therapeutic targets in glucose, nucleotides and lipids metabolism during cancer and neurological diseases
    Snežana M Jovičić, 2024, Int J Immunopathol Pharmacol CrossRef
  36. null
    Alan Clavelland Ochioni et al, 2024 CrossRef